本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Phio Pharmaceuticals

1.03
+0.02001.98%
盤前1.030.00000.00%05:10 EDT
成交量:9.56萬
成交額:9.93萬
市值:1,196.58萬
市盈率:-0.77
高:1.05
開:1.03
低:1.03
收:1.01
52周最高:4.19
52周最低:0.8127
股本:1,161.73萬
流通股本:1,154.81萬
量比:0.62
換手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-1.3423
每股收益(LYR):-1.4535
淨資產收益率:-113.71%
總資產收益率:-65.77%
市淨率:0.95
市盈率(LYR):-0.71

資料載入中...

2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/10

重要事件披露

8-K - Current report
2021/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/12

重要事件披露

8-K - Current report
2021/06/21

重要事件披露

8-K - Current report
2021/05/19

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/25

重要事件披露

8-K - Current report
2021/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

重要事件披露

8-K - Current report
2021/01/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals